Home › Stocks › AVLN › Changes
Who bought & sold AVLN (Q2 2026)
Funds holding (Q2 2026)94
New positions94
Added0
Reduced0
Exited0
As of Q2 2026, 94 institutional funds reported holding AVLN (AVALYN PHARMACEUTICALS INC): 94 opened new positions, 0 added, 0 trimmed and 0 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.
New positions (20 of 94)
| Fund | Shares | Value | Weight |
|---|---|---|---|
| Fidelity Management & Research (FMR) New | 5.84M | $192.10M | 0.0 |
| Novo Holdings A/S New | 3.88M | $127.84M | 7.4 |
| SR ONE CAPITAL MANAGEMENT, LP New | 3.31M | $108.92M | 10.5 |
| PERCEPTIVE ADVISORS LLC New | 2.68M | $88.07M | 1.4 |
| MONTANOVA CAPITAL, LLC New | 2.50M | $82.40M | 1.5 |
| NVP Associates, LLC New | 2.27M | $74.68M | 22.8 |
| WELLINGTON MANAGEMENT GROUP LLP New | 2.20M | $72.49M | 0.0 |
| PRICE T ROWE ASSOCIATES INC /MD/ New | 1.74M | $57.12M | 0.0 |
| Catalio Capital Management, LP New | 1.68M | $55.17M | 10.4 |
| T. Rowe Price Investment Management, Inc. New | 1.60M | $52.76M | 0.0 |
| EVENTIDE ASSET MANAGEMENT, LLC New | 1.38M | $45.28M | 0.6 |
| Bellevue Group AG New | 1.35M | $44.44M | 0.9 |
| BlackRock Inc New | 977.26K | $32.17M | 0.0 |
| Pivotal bioVenture Partners Investment Advisor LLC New | 966.79K | $31.83M | 10.3 |
| Citadel Advisors New | 959.10K | $31.57M | 0.0 |
| Andera Partners New | 929.82K | $30.61M | 14.8 |
| JENNISON ASSOCIATES LLC New | 812.75K | $26.76M | 0.0 |
| BRAIDWELL LP New | 801.39K | $26.38M | 1.0 |
| TPG GP A, LLC New | 773.07K | $25.45M | 0.5 |
| VANGUARD CAPITAL MANAGEMENT LLC New | 739.77K | $24.35M | 0.0 |
Added to positions (0)
No adds this quarter.
Reduced positions (0)
No trims this quarter.
Exited positions (0)
No exits this quarter.